Glenmark partners with Pfizer to launch Abrocitinib in India EP News Bureau Jan 31, 2024 When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively
Pfizer’s phase-III Jade trial shows positive results EP News Bureau Sep 1, 2021 The trial compares the efficacy of abrocitinib and dupilumab for moderate-to-severe atopic dermatitisa
